Clinuvel Pharmaceuticals

Clinuvel Pharmaceuticals

Verified
Global bio pharmaceutical developing drugs for severe skin disorder.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
AUD611m (Public information from Jul 2024)
Company register number 089644119
Melbourne Victoria (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
AUD2020202120222023202420252026
Revenues32.6m48.0m65.7m78.3m89.5m98.6m113m
% growth-47 %37 %19 %14 %10 %14 %
EBITDA13.6m28.2m37.4m49.6m43.8m49.0m56.6m
% EBITDA margin42 %59 %57 %63 %49 %50 %50 %
Profit16.6m24.7m20.9m30.6m34.7m37.5m42.8m
% profit margin51 %52 %32 %39 %39 %38 %38 %
EV / revenue36.9x29.9x9.3x9.3x6.3x5.4x4.4x
EV / EBITDA88.4x50.9x16.4x14.7x13.0x10.9x8.8x
  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO
*
N/A

AUD10.0m

Post IPO Equity
Total Funding-

Recent News about Clinuvel Pharmaceuticals

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.